Cytokine gene variants and venous thrombotic risk in the BRATROS (BRAZILIAN THROMBOSIS STUDY)
Loading...
External sources
External sources
Date
Advisor
Coadvisor
Graduate program
Undergraduate course
Journal Title
Journal ISSN
Volume Title
Publisher
Type
Article
Access right
Acesso restrito
External sources
External sources
Abstract
Introduction: Venous thrombosis (VT) and inflammation are two closely related entities. In the present investigation we assessed whether there is a relation between genetic modifiers of the inflammatory response and the risk of VT. Materials and methods: 420 consecutive and unrelated patients with an objective diagnosis of deep VT and 420 matched controls were investigated. The frequencies of the following gene polymorphisms were determined in all subjects: TNF-α- 308 G/A, LT-α+ 252 A/G, IL-6-174 G/C, IL1-ra 86 bp VNTR, IL-10-1082 A/G and CD-31 125 C/G. Results: Overall odds ratio (OR) for VT related to TNF-α- 308 G/A, LT-α+ 252 A/G, IL-6-174 G/C, A1 allele (4 bp repeat) of the IL1-ra 86 bp VNTR, IL-10-1082 A/G and CD-31 125 C/G were respectively: 1.0 (CI95: 0.8-1.5), 1.3 (CI95: 1.0-1.7), 1.1 (CI95: 0.9-1.5), 1.6 (CI95: 1-2.5), 1.2 (CI95: 0.8-1.7) and 0.8 (CI95: 0.6-1.1). A possible interaction between polymorphisms was observed only for the co-inheritance of the mutant alleles of the LT-α+ 252 A/G and IL-10-1082 G/A polymorphisms (OR = 2; CI95: 1.1-3.8). The risk of VT conferred by factor V Leiden and FII G20210A was not substantially altered by co-inheritance with any of the cytokine gene polymorphisms. Conclusions: Cytokine gene polymorphisms here investigated did not significantly influence venous thrombotic risk. © 2006 Elsevier Ltd. All rights reserved.
Description
Keywords
Coagulation , Cytokines , Inflammation , Polymorphisms , Thrombosis , Venous thromboembolism , blood clotting factor 11 , blood clotting factor 5 Leiden , CD31 antigen , cytokine , interleukin 1 receptor blocking agent , interleukin 10 , interleukin 6 , lymphotoxin , tumor necrosis factor alpha , cardiovascular risk , deep vein thrombosis , genetic polymorphism , inflammation , major clinical study , medical research , Base Sequence , Case-Control Studies , DNA Primers , Interleukin 1 Receptor Antagonist Protein , Interleukin-10 , Interleukin-6 , Lymphotoxin-alpha , Middle Aged , Odds Ratio , Polymorphism, Genetic , Tumor Necrosis Factor-alpha , Variation (Genetics) , Venous Thrombosis
Language
English
Citation
Thrombosis Research, v. 120, n. 2, p. 221-229, 2007.





